Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -62.07% is 29% above its 5-year average of -87.01%, near the high end of its 5-year range (-318.63%–-40.50%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.41% below its 12-month average of -50.71%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -62.07%.
RETURN ON EQUITY (ROE)
-62.07%
RETURN ON EQUITY (ROE) AVG TTM
-50.71%
RETURN ON EQUITY (ROE) AVG 3Y
-54.89%
RETURN ON EQUITY (ROE) AVG 5Y
-87.01%
RETURN ON EQUITY (ROE) AVG 10Y
-59.55%
RETURN ON EQUITY (ROE) AVG 15Y
-93.43%
RETURN ON EQUITY (ROE) AVG 20Y
-105.54%
CURRENT VS TTM AVG
-22.41%
CURRENT VS 3Y AVG
-13.08%
CURRENT VS 5Y AVG
+28.66%
CURRENT VS 10Y AVG
-4.24%
CURRENT VS 15Y AVG
+33.56%
CURRENT VS 20Y AVG
+41.18%
SECTOR MEDIAN · HEALTHCARE
-40.75%
median of 681 covered companies
CURRENT VS SECTOR MEDIAN
-52.33%
vs the sector median at left
Madrigal Pharmaceuticals, Inc.
Market Cap
$11.49B
Return on Equity (ROE)
-62.07%
TTM Avg
-50.71%
3Y Avg
-54.89%
5Y Avg
-87.01%
Market Cap
$11.34B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$11.67B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$10.97B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$10.87B
Return on Equity (ROE)
1.15%
TTM Avg
6.63%
3Y Avg
4.94%
5Y Avg
6.51%
Market Cap
$10.67B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$12.37B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$12.50B
Return on Equity (ROE)
-17.13%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$12.44B
Return on Equity (ROE)
14.35%
TTM Avg
4.54%
3Y Avg
-6.13%
5Y Avg
-2.52%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | $11.49B | -62.07% | -50.71% | -54.89% | -87.01% |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 8.63% | 6.23% | 8.78% | 10.01% |
| DaVita Inc. (DVA)vs › | $11.67B | N/A | 329.18% | 200.63% | 164.66% |
| The Cooper Companies, Inc. (COO)vs › | $10.97B | 6.85% | 4.70% | 4.67% | 11.22% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 1.15% | 6.63% | 4.94% | 6.51% |
| Universal Health Services, Inc. (UHS)vs › | $10.67B | 20.31% | 18.80% | 15.17% | 15.31% |
| Encompass Health Corporation (EHC)vs › | $12.37B | 23.91% | 22.63% | 21.83% | 21.13% |
| Baxter International Inc. (BAX)vs › | $12.50B | -17.13% | -12.46% | -8.76% | -1.37% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.44B | 14.35% | 4.54% | -6.13% | -2.52% |
| ICON Public Limited Company (ICLR)vs › | $12.51B | 3.51% | 5.40% | 5.85% | 7.17% |
ROE
-62.1%
ROA
-26.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -62.07% |
| 2026-03-31 | -56.94% |
| 2025-12-31 | -47.83% |
| 2025-09-30 | -46.21% |
| 2025-06-30 | -40.50% |
| 2025-03-31 | -55.10% |
| 2024-12-31 | -61.76% |
| 2024-09-30 | -66.74% |
| 2024-06-30 | -59.55% |
| 2024-03-31 | -52.22% |
| 2023-12-31 | -92.18% |
| 2023-06-30 | -318.63% |
| 2023-03-31 | -209.63% |
| 2022-12-31 | -149.63% |
| 2022-06-30 | -306.34% |
| 2022-03-31 | -169.35% |
| 2021-12-31 | -123.32% |
| 2021-09-30 | -100.66% |
| 2021-06-30 | -85.45% |
| 2021-03-31 | -83.92% |
| 2020-12-31 | -84.28% |
| 2020-09-30 | -58.98% |
| 2020-06-30 | -39.17% |
| 2020-03-31 | -27.24% |
| 2019-12-31 | -20.15% |
| 2019-09-30 | -15.37% |
| 2019-06-30 | -11.98% |
| 2019-03-31 | -8.86% |
| 2018-12-31 | -6.88% |
| 2018-09-30 | -6.17% |
| 2018-06-30 | -6.10% |
| 2018-03-31 | -17.79% |
| 2017-12-31 | -17.09% |
| 2017-09-30 | -56.08% |
| 2017-06-30 | -58.65% |
| 2017-03-31 | -89.04% |
| 2016-12-31 | -85.69% |
| 2016-09-30 | -90.41% |
| 2016-06-30 | -90.36% |
| 2016-03-31 | -122.91% |
| 2015-12-31 | -136.23% |
| 2015-09-30 | -130.01% |
| 2015-06-30 | -117.17% |
| 2015-03-31 | -180.56% |
| 2014-12-31 | -132.28% |
| 2014-09-30 | -107.46% |
| 2014-06-30 | -125.03% |
| 2014-03-31 | -243.36% |
| 2013-12-31 | -183.72% |
| 2013-09-30 | -575.92% |
| 2013-06-30 | -216.26% |
| 2013-03-31 | -120.96% |
| 2012-12-31 | -83.65% |
| 2012-09-30 | -172.13% |
| 2012-06-30 | -259.71% |
| 2012-03-31 | -151.11% |
| 2011-12-31 | -320.70% |
| 2011-09-30 | -184.94% |
| 2011-06-30 | -117.98% |
| 2011-03-31 | -301.96% |
| 2010-12-31 | -159.58% |
| 2010-09-30 | -135.87% |
| 2010-06-30 | 260.99% |
| 2010-03-31 | 214.98% |
| 2009-12-31 | 317.48% |
| 2009-09-30 | 195.14% |
| 2008-03-31 | -604.10% |
| 2007-12-31 | -255.04% |
| 2007-09-30 | -154.74% |
| 2007-06-30 | -113.44% |
| 2007-03-31 | -82.97% |
| 2006-09-30 | -572.54% |
| 2005-12-31 | -165.26% |
